A Phase I study of MAX-10181 given orally to patients with advanced solid tumors

  • Day, Daphne (Primary Chief Investigator (PCI))
  • Frentzas, Sophia (Primary Chief Investigator (PCI))

Project: Research

Project Details

StatusActive
Effective start/end date10/02/20 → 9/02/25

Keywords

  • clinical trial
  • phase 1 study
  • treatment efficacy
  • solid tumour